Company Filing History:
1 out of 832,880 Years Active: 2022
Title: Glenn F Short, III: Innovator in Heterocyclic Inhibitors
Introduction
Glenn F Short, III is a notable inventor based in Scituate, MA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target sodium channel activity. His work is crucial for addressing various medical conditions.
Latest Patents
Glenn F Short, III holds a patent for "Heterocyclic inhibitors of the sodium channel." This invention relates to compounds that are useful in treating conditions associated with voltage-gated ion channel function. Specifically, it concerns heterocyclic compounds that can be utilized in the treatment of epilepsy, cancer, pain, migraine, Parkinson's Disease, mood disorders, schizophrenia, psychosis, tinnitus, amyotrophic lateral sclerosis, glaucoma, ischemia, spasticity disorders, obsessive-compulsive disorder, restless leg syndrome, and Tourette syndrome. He has 1 patent to his name.
Career Highlights
Throughout his career, Glenn has focused on the development of innovative therapeutic solutions. His research has the potential to impact a wide range of neurological and psychological conditions, making him a valuable contributor to the field of pharmacology.
Collaborations
Glenn has worked alongside talented colleagues, including Donna Lee Romero and Margaret S Lee. Their collaborative efforts have further advanced the research and development of new therapeutic compounds.
Conclusion
Glenn F Short, III is a distinguished inventor whose work in heterocyclic inhibitors has the potential to transform treatment options for various medical conditions. His contributions to the field of medicinal chemistry are noteworthy and continue to inspire future innovations.